🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 92915B102
- Market Cap
- Mid Cap
- IPO
- 5/10/2015 · $14.00/share
Business: Voyager Therapeutics, Inc. is a clinical-stage gene therapy company. The Company focuses on developing life-changing treatments for patients suffering from severe diseases of the central nervous system (CNS). Its product engine has generated programs for five CNS indications, including advanced Parkinson's disease; a monogenic form of amyotrophic lateral sclerosis; Friedreich's ataxia; Huntington's disease, and spinal muscular atrophy.
Company Contact
- CEO
- Al Sandrock
- CFO
- Nathan Jorgensen
- Headquarters
- 64 Sidney Street, Cambridge, MA 02139
- Phone
- 857-259-5340
- Investor Relations
- Andrew Funderburk · afunderburk@kendallir.com